332 related articles for article (PubMed ID: 25088038)
1. NEDD4: a promising target for cancer therapy.
Ye X; Wang L; Shang B; Wang Z; Wei W
Curr Cancer Drug Targets; 2014; 14(6):549-56. PubMed ID: 25088038
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of SIRT1 by 17β-estradiol depends on ubiquitin-proteasome degradation of PPAR-γ mediated by NEDD4-1.
Han L; Wang P; Zhao G; Wang H; Wang M; Chen J; Tong T
Protein Cell; 2013 Apr; 4(4):310-21. PubMed ID: 23549616
[TBL] [Abstract][Full Text] [Related]
3. NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer.
Tian X; Chen Y; Peng Z; Lin Q; Sun A
Biochem Pharmacol; 2023 Aug; 214():115641. PubMed ID: 37307883
[TBL] [Abstract][Full Text] [Related]
4. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.
Lin Q; Wang J; Childress C; Sudol M; Carey DJ; Yang W
Mol Cell Biol; 2010 Mar; 30(6):1541-54. PubMed ID: 20086093
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer.
Jayaprakash S; Hegde M; BharathwajChetty B; Girisa S; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293239
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
Crosas B
Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
[TBL] [Abstract][Full Text] [Related]
7. Indole-3-carbinol (I3C) analogues are potent small molecule inhibitors of NEDD4-1 ubiquitin ligase activity that disrupt proliferation of human melanoma cells.
Quirit JG; Lavrenov SN; Poindexter K; Xu J; Kyauk C; Durkin KA; Aronchik I; Tomasiak T; Solomatin YA; Preobrazhenskaya MN; Firestone GL
Biochem Pharmacol; 2017 Mar; 127():13-27. PubMed ID: 27979631
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
[TBL] [Abstract][Full Text] [Related]
9. Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.
Dou QP; Zonder JA
Curr Cancer Drug Targets; 2014; 14(6):517-36. PubMed ID: 25092212
[TBL] [Abstract][Full Text] [Related]
10. Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.
Landré V; Rotblat B; Melino S; Bernassola F; Melino G
Oncotarget; 2014 Sep; 5(18):7988-8013. PubMed ID: 25237759
[TBL] [Abstract][Full Text] [Related]
11. NEDD4 E3 Ligases: Functions and Mechanisms in Bone and Tooth.
Xu K; Chu Y; Liu Q; Fan W; He H; Huang F
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077334
[TBL] [Abstract][Full Text] [Related]
12. Calcium activates Nedd4 E3 ubiquitin ligases by releasing the C2 domain-mediated auto-inhibition.
Wang J; Peng Q; Lin Q; Childress C; Carey D; Yang W
J Biol Chem; 2010 Apr; 285(16):12279-88. PubMed ID: 20172859
[TBL] [Abstract][Full Text] [Related]
13. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
Kitagawa K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
Park J; Cho J; Song EJ
Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
[TBL] [Abstract][Full Text] [Related]
15. Physiological Functions of the Ubiquitin Ligases Nedd4-1 and Nedd4-2.
Rotin D; Prag G
Physiology (Bethesda); 2024 Jan; 39(1):18-29. PubMed ID: 37962894
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase NEDD4-1 during neuronal response to zinc.
Kwak YD; Wang B; Pan W; Xu H; Jiang X; Liao FF
J Biol Chem; 2010 Mar; 285(13):9847-9857. PubMed ID: 20100827
[TBL] [Abstract][Full Text] [Related]
17. NEDD4: The founding member of a family of ubiquitin-protein ligases.
Boase NA; Kumar S
Gene; 2015 Feb; 557(2):113-22. PubMed ID: 25527121
[TBL] [Abstract][Full Text] [Related]
18. Molecular functions of NEDD4 E3 ubiquitin ligases in cancer.
Zou X; Levy-Cohen G; Blank M
Biochim Biophys Acta; 2015 Aug; 1856(1):91-106. PubMed ID: 26116757
[TBL] [Abstract][Full Text] [Related]
19. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
Masumoto K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
[TBL] [Abstract][Full Text] [Related]
20. The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling.
Huang Z; Choi BK; Mujoo K; Fan X; Fa M; Mukherjee S; Owiti N; Zhang N; An Z
Oncogene; 2015 Feb; 34(9):1105-15. PubMed ID: 24662824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
